Nadim Ahmed Cullinan Oncology, Inc. (CGEM) insider trading activity

CGEM Quotes by TradingView

Nadim Ahmed is President and CEO of Cullinan Oncology, Inc.. Currently has a direct ownership of 430,621 shares of CGEM, which is worth approximately $3.91 Million. The most recent transaction as insider was on Feb 25, 2025, when has been sold 12,529 shares (Common Stock) at a price of $8.53 per share, resulting in proceeds of $106,872. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 431K
58.58% 3M change
58.58% 12M change
Total Value Held $3.91 Million

NADIM AHMED Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 25 2025
SELL
Open market or private sale
$106,872 $8.53 p/Share
12,529 Reduced 2.83%
430,621 Common Stock
Feb 19 2025
BUY
Grant, award, or other acquisition
-
180,000 Added 28.89%
443,150 Common Stock
Dec 24 2024
SELL
Open market or private sale
$99,708 $11.87 p/Share
8,400 Reduced 3.09%
263,150 Common Stock
Feb 22 2024
BUY
Grant, award, or other acquisition
-
160,000 Added 37.08%
271,550 Common Stock
Dec 26 2023
SELL
Open market or private sale
$39,473 $9.24 p/Share
4,272 Reduced 3.69%
111,550 Common Stock
Jun 28 2023
SELL
Open market or private sale
$8,652 $11.4 p/Share
759 Reduced 0.65%
115,822 Common Stock
May 23 2023
SELL
Open market or private sale
$6,469 $9.15 p/Share
707 Reduced 0.6%
116,581 Common Stock
Apr 25 2023
SELL
Open market or private sale
$7,582 $10.59 p/Share
716 Reduced 0.61%
117,288 Common Stock
Mar 23 2023
SELL
Open market or private sale
$7,420 $10.51 p/Share
706 Reduced 0.59%
118,004 Common Stock
Feb 22 2023
BUY
Grant, award, or other acquisition
-
109,000 Added 47.87%
118,710 Common Stock
Jun 30 2022
BUY
Grant, award, or other acquisition
$17,658 $10.9 p/Share
1,620 Added 14.3%
9,710 Common Stock
Jun 06 2022
BUY
Open market or private purchase
$100,316 $12.4 p/Share
8,090 Added 50.0%
8,090 Common Stock

Also insider at

BMY
BRISTOL MYERS SQUIBB CO Healthcare
EVP and President, Hematology
NA

Nadim Ahmed

President and CEO
New York, NY

Track Institutional and Insider Activities on CGEM

Follow Cullinan Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CGEM shares.

Notify only if

Insider Trading

Get notified when an Cullinan Oncology, Inc. insider buys or sells CGEM shares.

Notify only if

News

Receive news related to Cullinan Oncology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CGEM